Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
AGIOS PHARMACEUTICALS, INC.Listing on record | Buy | $25.3M | conv 45Unusual size | SEC | |
AGIOS PHARMACEUTICALS, INC.Listing on record | Buy | $13M | conv 30 | SEC | |
Epizyme, Inc.Listing unverified | Buy | $9.9M | conv 46Cluster | SEC | |
Epizyme, Inc.Listing unverified | Buy | $1M | conv 42ClusterFirst in 12mo | SEC | |
Epizyme, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Epizyme, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC |